Senores Pharmaceuticals Ltd (NSE:SENORES)

Q4 2026 Senores Pharmaceuticals Ltd Earnings Call Transcript

May 14, 2026 / 11:30 AM GMT

Release Date Price: ₹954.65 (-1.96%)

Transcript

Key Points

Positve

Senores Pharmaceuticals Ltd (NSE:SENORES) achieved a 62% revenue growth and 108% profit growth over FY25, surpassing their guidance.
The company reported a robust performance in regulated markets with an 83% year-over-year growth in FY26.
Senores Pharmaceuticals Ltd expanded its ANDA portfolio significantly, with 51 approved ANDAs as of March 2026.
The acquisition of a 75% stake in Applant Pharma enhances manufacturing capacity and operational flexibility.
The company has a strong product pipeline and expanded manufacturing capacity, supporting future growth projections.

Negative

Working capital days increased significantly from 114 days in FY25 to 187 days in FY26.
The company's tax rate increased from 17% in FY25 to 23.6% in FY26, impacting net profitability.
There is uncertainty in the external environment, including inflationary pressures and shipping line issues, which may affect future growth.
The company has a high level of unbilled revenue, which may impact cash flow if not realized promptly.
Despite strong growth, the company remains conservative in its future guidance due to macroeconomic uncertainties.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SENO.NS - Senores Pharmaceuticals Ltd
Q4 2026 Senores Pharmaceuticals Ltd Earnings Call
May 14, 2026 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and Gentlemen, Good day and welcome to Senaris Pharmaceuticals Limited Q4 FY26 Earnings Conference Call hosted by Ambit Capital.

This conference call may contain forward-looking statements about the company which are based on beliefs, opinions and expectations of the company as on the date of this call.

These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict.

As a reminder, all participants will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.